In this study, we synthesised twenty-four 2–(2-phenylethyl) chromone derivatives, assessed their anti-CYP1B1 activity that is implicated in clinical anti-tumour drug resistance and selectivity towards tissue-distributed CYP1A2, and established structure-activity relationships for ring A/B substituents. This evidence concerns the gene CYP1B1 and neoplasm.